Skip to content
Opinion
Lisa Jarvis and Sam Fazeli

What Covid Treatment Will Cost You in 2023

The US government will soon stop paying for vaccines, monoclonal antibodies and drugs like Paxlovid. That's bad news for already-weak demand.

Antibody infusions could cost patients more than $2,000 a pop.

Antibody infusions could cost patients more than $2,000 a pop.

Photographer: Bloomberg

Covid-19 funding in the US has nearly run out and unless Congress renews it, consumers could soon find themselves on the hook for vaccines and treatments that were previously free.

Last week, the Department of Health and Human Services said that commercial sales of coronavirus vaccines, previously distributed by the US government and offered at no cost to anyone who wanted them, could begin in early 2023. Some treatments, which also were largely free, are already transitioning to the commercial market; others will follow early next year.